NKR-mediated control of γδ T-cell immunity to viruses

Microbes and Infection

Volumn 1, Issue 3, 1999, Pages 219-226

  Gougeon, Marie Lise ^a   Boullier, Séverine ^b   Colizzi, Vittorio ^c   Poccia, Fabrizio ^c  

^a Inst P   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; LYMPHOCYTE RECEPTOR; NATURAL KILLER CELL RECEPTOR; UNCLASSIFIED DRUG;

CELLULAR IMMUNITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; MOLECULAR DYNAMICS; NATURAL KILLER CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; T LYMPHOCYTE SUBPOPULATION; VIRUS IMMUNITY;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0032756451     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(99)80037-9     Document Type: Note

References (77)

1. + dendritic epidermal cells. Cell. 55:1988;837-847.
2. Autran B., Triebel F., Katlama C., Rozembaum W., Hercend T., Debre P. T cell receptor gamma delta lymphocytes subsets during HIV infection. Clin. Exp. Immunol. 75:1989;206-210.
3. Babbitt B.P., Allen P.M., Matsueda Γ.Δ., Haber E., Unanue E.R. Binding of immunogenic peptides to Ia histocompatibility molecules. Nature. 317:1985;359-361.
4. Battistini L., Borsellino G., Sawicki G., Poccia F., Salvetti M., Ristori G., Brosnan C. Phenotypic and cytokine analysis of human peripheral blood γδ T cells expressing natural killer receptors. J. Immunol. 159:1997;3723-3730.
5. Beckman E.M., Porcelli S.A., Morita C.T., Behar S.M., Furlong S.T., Brenner M.B. Recognition of a lipid antigen by CD1-restricted αβ T cells. Nature. 372:1994;691-694.
6. Behr C., Poupot R., Peyrat M.A., Poquet Y., Constant P., Dubois P., Bonneville M., Fournié J.J. Plasmodium falciparum stimuli for human gamma delta T cells are related to phosphorylated antigens of mycobacteria. Infect. Immun. 64:1996;2892-2896.
7. Bertotto A., Gerli R., Spinozzi C., Muscat F., Scalise F., Castellucci G., Sposito M., Candio F., Vaccaro R. Lymphocytes bearing the γδ T cell receptor in acute Brucella melitensis infection. Eur. J. Immunol. 23:1993;1177-1180.
8. Bjorkman P.J., Saper M.A., Samraoui B., Bennett W.S., Strominger J.L., Wiley D.C. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature. 329:1987;512-518.
9. Bleul C.C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., Springer T.A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature. 382:1996;829-832.
10. Borrego F., Ulbrecht M., Weiss E., Coligan J.E., Brooks A.G. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. M. 187:1998;813-818.
11. Boullier S., Poquet Y., Debord T., Fournié J.J., Gougeon M.L. Th1 (IL-12 and IL-15) and Th2 (IL-4 and IL-10)-dependent regulation of Vγ9Vδ2 response to mycobacterial phosphoantigens in responder and anergic HIV-infected persons. Eur. J. Immunol. 29:1999;90-99.
12. Boullier S., Poquet Y., Halary F., Bonneville M., Fournié J.J., Gougeon M.L. Phosphoantigen activation induces surface translocation of intracellular CD94/NKG2A class I receptor on CD94 negative peripheral Vγ9Vδ2 T cells but not on CD94 negative thymic or mature γδ T cell clones. Eur. J. Immunol. 28:1998;3399-3410.
13. Boullier S., Dadaglio G., Lafeuillade A., Debord T., Gougeon M.L. V delta 1 T cells expanded in the blood throughout HIV infection display a cytotoxic activity and are primed for TNF-alpha and IFN-gamma production but are not selected in lymph nodes. J. Immunol. 159:1997;3629-3637.
14. + T cell expansion in the peripheral blood of HIV-infected persons. J. Immunol. 154:1995;1418-1431.
15. Braud M.V., Allan D.S.J., OCallaghan C.A., Söderström K., DAndrea A., Ogg G.S., Lazetic S., Young N.T., Bell J.I., Phillips J.H., Lanier L.L., McMichael A.J. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 391:1998;795-799.
16. Burk M.R., Mori L., De Libero G. Human V gamma 9-V delta 2 cells are stimulated in a cross-reactive fashion by a variety of phosphorylated metabolites. Eur. J. Immunol. 25:1995;2052-2058.
17. Bukowski J.F., Morita C.T., Brenner M.B. Recognition and destruction of virus-infected cells by human γδ CTL. J. Immunol. 153:1994;5133-5140.
18. Carena I., Shamshiev A., Donda C., Colonna M., De Libero G. Major histocompatibility complex class I molecules modulate activation threshold and early signalling of T cell antigen receptor-γδ stimulated by nonpeptidic ligand. J. Exp. M. 186:1997;1769-1774.
19. Carretero M., Palmieri G., Llano M., Tullio V., Santoni A., Geraghty D.E., Lopez Botet M. Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class IB molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2A. Evidence for receptor function in heterologous transfectants. Eur. J. Immunol. 28:1998;1280-1291.
20. Clerici M., Shearer G.M. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol. Today. 15:1994;575-581.
21. + T cells. Science. 270:1995;1811-1815.
22. Constant P., Davodeau F., Peyrat M.A., Poquet Y., Puzo G., Bonneville M., Fournié J.J. Stimulation of γδ T cells by nonpeptidic mycobacterial ligands. Science. 264:1994;267-270.
23. De Maria A., Ferraris A., Guastella M., Pilia S., Cantoni C., Polero L., Mingari M.C., Bassetti D., Fauci A.S., Moretta L. Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functions. Proc. Natl. Acad. Sci. USA. 94:1997;10285-10288.
24. De Maria A., Ferazin A., Ferrini S., Ciccone E., Terragna A., Moretta L. Selective increase of a subset of T cell receptor gamma delta T lymphocytes in the peripheral blood of patients with human immunodeficiency virus type 1 infection. J. Infect. Dis. 165:1992;917-919.
25. De Paoli P., Gennari D., Martelli P., Basaglia G., Crovatto M., Battistin S., Santini G. A subset of gamma delta lymphocytes is increased during HIV-1 infection. Clin. Exp. Immunol. 83:1991;187-196.
26. De Paoli P., Gennari D., Martelli P., Cavarzerani V., Comoretto R. Santini G., γδ T cell receptor-bearing lymphocytes during Epstein-Barr virus infection. J. Inf. Dis. 161:1990;1013-1016.
27. Ferrarini M., Heltai S., Toninelli E., Sabbadini M.G., Pellicciari C., Manfredi A.A. Daudi lymphoma killing triggers the programmed death of cytotoxic Vγ9Vδ2 T lymphocytes. J. Immunol. 154:1995;3704-3712.
28. Fisch P., Meuer E., Pende D., Rothenfusser S., Viale O., Kock S., Ferrone S., Fradelizi D., Klein G., Moretta L., Rammensee H., Boon T., Coulie P., Vanderbruggen P. Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vγ9 /Vδ2 T cells in tumor immunity. Eur. J. Immunol. 27:1997;3368-3379.
29. Fisch P., Malkovsky M., Kovats S., Strum E., Braakman E., Klein B.S., Voss S.D., Morrissey L.W., Demars R., Welch W.J., Bolhuis R.L.H., Sondel P.M. Recognition by human Vγ9/Vδ2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells. Science. 250:1990;1269-1273.
30. Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., Bloom B.R. An essential role for interferon γδ in resistance to Mycobacterium tuberculosis infection. J. Exp. M. 178:1993;2249-2254.
31. Fournié J.J., Bonneville M. Stimulation of γδ T cells by phosphoantigens. Res. Immunol. 147:1996;338-347.
32. Gan Y.H., Malkovsky M. Mechanisms of simian gamma delta T cell cytotoxicity against tumor and immunodeficiency virus-infected cells. Immunol. Letters. 49:1996;191-196.
33. Groh V., Steinle A., Bauer S., Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells. Science. 279:1998;1737-1740.
34. Groh V., Porcelli S., Fabbi M., Lanier L.L., Picker L.J., Anderson T., Warnke R.A., Bhan A.K., Strominger J.L., Brenner M.B. Human lymphocytes bearing T cell receptor γδ/δ are phenotypically diverse and distributed throughout the lymphoid system. J. Exp. M. 169:1989;1277-1294.
35. + subset of human γδ T cells responds to ligands expressed by EBV-infected Burkitt lymphoma cells and transformed B lymphocytes. J. Immunol. 149:1992;3984-3989.
36. Halary F., Peyrat M.A., Champagne E., Lopez-Botet M., Moretta A., Moretta L., Vie H., Fournié J.J., Bonneville M. Control of self-reactive cytotoxic T lymphocytes expressing gamma-delta T cell receptors by natural killer inhibitory receptors. Eur. J. Immunol. 27:1997;2812-2821.
37. Hara T., Mizuno Y., Takaki K., Takada H., Akeda H., Aoki T., Nagata M., Ueda K., Matsuzaki G., Yoshikai Y. Predominant activation and expansion of Vγ9-bearing γδ T cells in vivo as well as in vitro in Salmonella infection. J. Clin. Invest. 90:1992;204-210.
38. Hiromatsu K., Yoshikai Y., Matsuzaki G., Ohga S., Muramori K., Matsumoto K., Bluestone J.A., Nomoto K. A protective role of gamma/delta T cells in primary infection with Listeria monocytogenes in mice. J. Exp. M. 175:1992;49-56.
39. + T lymphocytes during progression of HIV infection. J. Immunol. 158:1997;464-474.
40. Howcroft T.K., Strebel K., Martin M.A., Singer D.S. Repression of MHC class I promoter activity by two-exon tat of HIV. Science. 260:1993;1320-1322.
41. Kabelitz D., Bender A., Prospero T., Wesselborg S., Janssen O., Pechhold K. The primary response of human gamma/delta T cells to Mycobacterium tuberculosis is restricted to V gamma 9-bearing cells. J. Exp. M. 173:1991;1331-1338.
42. Koning F., Knot M., Wassenaar F., van den Elsen P. Phenotypical heterogeneity among human T cell receptor gamma-delta-expressing clones derived from peripheral blood. Eur. J. Immunol. 19:1989;2099-2105.
43. Ladel C.H., Hess J., Daugelat S., Mombaerts P., Tonegawa S., Kaufmann S.H.E. Contribution of αβ and γδ T lymphocytes to immunity against Mycobacterium bovis bacillus Calmette Guerin: studies with T cell receptor deficient mutant mice. Eur. J. Immunol. 25:1995;838-846.
44. Lang F., Peyrat M.A., Constant P., Davodeau F., Hallet M.M., DavidAmeline J., Poquet Y., Vie H., Fournié J.J., Bonneville M. Early activation of human Vγ9Vδ2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands. J. Immunol. 154:1995;5986-5994.
45. Lanier L.L., Phillips J.H. Inhibitory MHC class I receptors on NK cells and T cells. Immunol. Today. 17:1996;86-91.
46. Lanier L.L., Ruitenberg J., Bolhuis R.L., Borst J., Phillips J.H., Testi R. Structural and serological heterogeneity of γδ/δ T cell antigen receptor expression in thymus and peripheral blood. Eur. J. Immunol. 18:1988;1985-1992.
47. Lee N., Llano M., Carretero M., Ishitani A., Navarro F., Lopez-Botet M., Geraghty D.E. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA. 95:1998;5199-5204.
48. Maccario R., Revello M.G., Comoli P., Montagna D., Locatelli F., Gerna G. HLA-unrestricted killing of HSV-1 infected mononuclear cells. J. Immunol. 150:1993;1437-1445.
49. Mingari M.C., Moretta A., Moretta L. Regulation of KIR expression in human T cells : a safety mechanism that may impair protective T-cell responses. Immunol. Today. 19:1998;153-157.
50. +) T cells. Proc. Nat. Acad. Sci. USA. 95:1998;1172-1177.
51. Mingari M.C., Vitale C., Cantoni C., Bellomo R., Ponte M., Schiavetti F., Bertone S., Moretta A., Moretta L. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Eur. J. Immunol. 27:1997;1374-1380.
52. + T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc. Natl. Acad. Sci. USA. 93:1996;12433-12438.
53. Modlin R.L., Pirmez C., Hofman F.M., Torigian V., Uyemura K., Rea T.H., Bloom B.R., Brenner M.B. Lymphocytes bearing antigen-specific gamma delta T-cell receptors accumulate in human infectious disease lesions. Nature. 339:1989;544-548.
54. Mombaerts P., Arnoldi J., Russ F., Tonegawa S., Kaufmann S.H. Different roles of αβ and γδ T cells in immunity against an intracellular bacterial pathogen. Nature. 365:1993;53-56.
55. Moretta A., Bottino C., Vitale M., Pende D., Biassoni R., Mingari M.C., Moretta L. Receptors for HLA class I molecules in human natural killer cells. Annu. Rev. Immunol. 14:1996;619-648.
56. Morita C.T., Beckman E.M., Bukowski J.F., Tanaka Y., Band H., Bloom B.B., Golan D.E., Brenner M.B. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human γδ T cells. Immunity. 3:1995;495-507.
57. Nakajima H., Tomiyama H., Takiguchi M. Inhibition of gamma delta T cell recognition by receptors for MHC class I molecules. J. Immunol. 155:1995;4139-4142.
58. Oberlin E., Amara A., Bachelerie F., Bessia C., Virelizier J.L., Arenzana-Seisdedos F., Schwartz O., Heard J.M., Clark-Lewis I., Legler D.F., Loetscher M., Baggiolini M., Moser B. The CXC chemochine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line adapted HIV-1. Nature. 382:1996;833-835.
59. Orsini D.L.M., Res P.C.M., van Laar J.M., Muller S., Soprano A.E.L., Kooy Y.M.C., Tak P.P., Koning F. A subset cells of Vd proliferate in response to Epstein-Barr virus-transformed B cell lines in vitro. Scand. J. Immunol. 38:1993;335-340.
60. Parker C.M., Groh V., Band H., Porcelli S.A., Morita C., Fabbi M., Glass D., Strominger J.L., Brenner M.B. Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire. J. Exp. M. 171:1990;1597-1612.
61. Phillips J.H., Chang C., Mattson J., Gumperz J.E., Parham P., Lanier L.L. CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. Immunity. 5:1996;163-172.
62. Poccia F., Gougeon M.L., Bonneville M., Lopez-Botet M., Moretta A., Battistini L., Wallace M., Colizzi V., Malkovsky M. Innate T cell immunity to nonpeptidic antigens and MHC class I recognition, Immunol. Today. 19:1998;253-256.
63. Poccia F., Cipriani B., Vendetti S., Colizzi V., Poquet Y., Battistini L., López-Botet M., Fournié J.J., Gougeon M.L. CD94/NKG2 Inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive Vγ9Vδ2 T lymphocytes. J. Immunol. 159:1997;6009-6017.
64. Poccia F., Malkovsky M., Gougeon M.L., Bonneville M., Lopez-Botet M., Fournié J.J., Colizzi V. γδ T cell activation or anergy during infections: the role of nonpeptidic TCR ligands and HLA class I molecules. J. Leuk. Biol. 62:1997;1-5.
65. Poccia F., Boullier S., Lecoeur H., Cochet M., Poquet Y., Colizzi V., Fournié J.J., Gougeon M.L. Peripheral Vγ9/Vδ2 T cell deletion and anergy to non-peptidic mycobacterial antigens in asymptomatic HIV-1 infected persons. J. Immunol. 157:1996;4449-4461.
66. Poquet Y., Halary F., Champagne E., Davodeau F., Gougeon M.L., Bonneville M., Fournié J.J. Human gamma delta T cells in tuberculosis. Res. Immunol. 147:1996;542-549.
67. Rosat J.P., Macdonald H.R., Louis J.A. A role for gamma delta T cells during experimental infection of mice with Leishmania major. J. Immunol. 150:1993;550-555.
68. Reyburn H.T., Mandelboim O., Valés-Gomez M., Davis D.M., Pazmany L., Strominger J.L. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature. 386:1997;514-516.
69. Rubio G., Aramburu J., Ontanon J., Lopez-Botet M., Aparicio P. A novel functional cell surface dimer (kp43) serves as accessory molecule for the activation of a subset of human gamma delta T cells. J. Immunol. 151:1993;1312-1321.
70. Sarin A., Conan-Cibotti M., Henkart P.A. Cytotoxic effect of TNF and lymphotoxin on T lymphoblasts. J. Immunol. 155:1995;3716-3718.
71. Schwartz O., Marechal V., LeGall S., Lemonnier F., Heard J.M. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. M. 2:1996;338-342.
72. Sivori S., Vitale M., Bottino C., Marcenaro E., Sanseverino L., Parolini S., Moretta L., Moretta A. CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur. J. Immunol. 26:1996;2487-2492.
73. Tanaka I., Morita C.T., Tanaka Y., Nieves E., Brenner M.B., Bloom B.R. Natural and synthetic non-peptide antigens recognized by human γδ T cells. Nature. 375:1995;155-158.
74. Ueta C., Tsuyuguchi I., Kawasumi H., Takashima T., Toba H., Kishimoto S. Increase of γδ T cells in hospital workers who are in contact with tuberculosis patients. Infect. Immun. 62:1994;5434-5441.
75. Wallace M., Scharko A.M., Pauza C.D., Fish P., Imaoka K., Kawabata S., Fujihashi K., Kiyono H., Tanaka Y., Bloom B.R., Malkovsky M. Functional γδ T cell defect associated with human immunodeficiency virus infection. Mol. M. 3:1997;60-711.
76. Wallace M., Bartz S.R., Chang W.L., Mackenzie D., Pauza C.D., Malkovsky M. γδ T lymphocyte responses to human immunodeficiency virus. Clin. Exp. Immunol. 103:1996;177-184.
77. Wallace M., Malkovsky M., Carding S.R. Gamma/delta T lymphocytes in viral infections. J. Leukoc. Biol. 58:1995;277-283.